Rights and permissions
About this article
Cite this article
Amfebutamone for second-line treatment only. React. Wkly. 873, 2 (2001). https://doi.org/10.2165/00128415-200108730-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200108730-00001